Production (Stage)
Sarepta Therapeutics, Inc.
SRPT
$37.60
-$1.01-2.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -248.39M | 235.24M | 121.85M | 47.30M | 16.90M |
| Total Depreciation and Amortization | 38.96M | 37.72M | 38.64M | 39.76M | 41.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 331.05M | 237.86M | 228.93M | 196.43M | 89.24M |
| Change in Net Operating Assets | -668.77M | -716.61M | -741.90M | -679.99M | -681.64M |
| Cash from Operations | -547.15M | -205.79M | -352.49M | -396.50M | -533.67M |
| Capital Expenditure | -148.16M | -136.96M | -117.91M | -110.32M | -99.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 393.75M | 892.52M | 45.00M | -44.34M | 139.57M |
| Cash from Investing | 245.59M | 755.56M | -72.92M | -154.66M | 40.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.28M | -68.00K | -- | -- | -- |
| Issuance of Common Stock | 73.07M | 79.53M | 77.76M | 79.41M | 45.35M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 45.35M | 45.35M | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 115.14M | 124.81M | 77.76M | 79.41M | 45.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.42M | 674.58M | -347.65M | -471.75M | -447.82M |